A D Bardeguez

Summary

Affiliation: New Jersey
Country: USA

Publications

  1. ncbi Effect of human immunodeficiency virus infection on serum beta2-microglobulin levels in pregnant women
    A D Bardeguez
    Department of Obstetrics, Gynecology, and Women s Health, New Jersey Medical School, Newark 07103, USA
    Obstet Gynecol 94:537-42. 1999
  2. ncbi Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival
    Arlene D Bardeguez
    University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, USA
    J Acquir Immune Defic Syndr 32:170-81. 2003
  3. ncbi Adherence to antiretrovirals among US women during and after pregnancy
    Arlene D Bardeguez
    Department of Obstetrics, Gynecology and Women s Health, University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark, NJ 07103 1709, USA
    J Acquir Immune Defic Syndr 48:408-17. 2008
  4. ncbi Pregnancy outcomes in young women with perinatally acquired human immunodeficiency virus-1
    Shauna F Williams
    Department of Obstetrics, Gynecology, and Women s Health, University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark, NJ 07101, USA
    Am J Obstet Gynecol 200:149.e1-5. 2009
  5. ncbi Effect of pregnancy and human immunodeficiency virus infection on intracellular interleukin-2 production patterns
    Madeline Y Sutton
    Department of Obstetrics, Gynecology and Women's Health, University of Medicine and Dentistry of New Jersey--New Jersey Medical School, Newark, New Jersey 07102, USA
    Clin Diagn Lab Immunol 11:780-5. 2004
  6. ncbi Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy
    Elizabeth G Livingston
    Duke University, Durham, NC 27710, USA
    Obstet Gynecol 110:391-7. 2007
  7. ncbi Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084
    Susan E Cohn
    Infectious Diseases Division, 601 Elmwood Avenue, Box 689, University of Rochester Medical Center, Rochester, New York 14642, USA
    AIDS Patient Care STDS 22:29-40. 2008

Detail Information

Publications7

  1. ncbi Effect of human immunodeficiency virus infection on serum beta2-microglobulin levels in pregnant women
    A D Bardeguez
    Department of Obstetrics, Gynecology, and Women s Health, New Jersey Medical School, Newark 07103, USA
    Obstet Gynecol 94:537-42. 1999
    ....
  2. ncbi Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival
    Arlene D Bardeguez
    University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, USA
    J Acquir Immune Defic Syndr 32:170-81. 2003
    ....
  3. ncbi Adherence to antiretrovirals among US women during and after pregnancy
    Arlene D Bardeguez
    Department of Obstetrics, Gynecology and Women s Health, University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark, NJ 07103 1709, USA
    J Acquir Immune Defic Syndr 48:408-17. 2008
    ..Antiretrovirals (ARVs) are recommended for maternal health and to reduce HIV-1 mother-to-child transmission, but suboptimal adherence can counteract its benefits...
  4. ncbi Pregnancy outcomes in young women with perinatally acquired human immunodeficiency virus-1
    Shauna F Williams
    Department of Obstetrics, Gynecology, and Women s Health, University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark, NJ 07101, USA
    Am J Obstet Gynecol 200:149.e1-5. 2009
    ..The objective of the study was to review pregnancy and neonatal outcomes among perinatally infected pregnant patients at our institution...
  5. ncbi Effect of pregnancy and human immunodeficiency virus infection on intracellular interleukin-2 production patterns
    Madeline Y Sutton
    Department of Obstetrics, Gynecology and Women's Health, University of Medicine and Dentistry of New Jersey--New Jersey Medical School, Newark, New Jersey 07102, USA
    Clin Diagn Lab Immunol 11:780-5. 2004
    ..This information is essential to assess the possible use of IL-2 supplementation therapy as a means of enhancing immune responses among HIV-infected pregnant women...
  6. ncbi Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy
    Elizabeth G Livingston
    Duke University, Durham, NC 27710, USA
    Obstet Gynecol 110:391-7. 2007
    ..To evaluate the effect of protease inhibitors on lipid and lactate levels and gastrointestinal symptoms in pregnancy...
  7. ncbi Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084
    Susan E Cohn
    Infectious Diseases Division, 601 Elmwood Avenue, Box 689, University of Rochester Medical Center, Rochester, New York 14642, USA
    AIDS Patient Care STDS 22:29-40. 2008
    ..84 times higher odds (p = 0.001) of ART nonadherence. Women reporting a history of illicit drug use and/or having missed prenatal vitamins should be targeted for programs to enhance adherence to ART during pregnancy...